Science:肠道病原体能利用人体修复机制让我们病倒

2016-09-20 佚名 生物探索

导语:为什么一些食源性细菌会使我们生病?一篇9月16日发表在Science杂志上的一篇论文发现,肠道中的病原体引起损害,是因为它们能从原本用来修复细菌起初对肠道损害的免疫系统反应中获益。为什么一些食源性细菌会使我们生病?一篇9月16日发表在Science杂志上的一篇论文发现,肠道中的病原体引起损害,是因为它们能从原本用来修复细菌起初对肠道损害的免疫系统反应中获益。加州大学戴维斯分校的通讯作者And

导语:为什么一些食源性细菌会使我们生病?一篇9月16日发表在Science杂志上的一篇论文发现,肠道中的病原体引起损害,是因为它们能从原本用来修复细菌起初对肠道损害的免疫系统反应中获益。

为什么一些食源性细菌会使我们生病?一篇9月16日发表在Science杂志上的一篇论文发现,肠道中的病原体引起损害,是因为它们能从原本用来修复细菌起初对肠道损害的免疫系统反应中获益。

加州大学戴维斯分校的通讯作者Andreas Bäumler教授说:“这个发现很重要,因为它解释了一些肠道病原菌可以利用哺乳动物细胞获得它们呼吸需要的氧气。这项发现还为针对肠道菌群的代谢,以防止有害细菌在肠道中扩张的新发展战略提供了展望。抗生素的滥用会加剧这种状况。”

病原菌将肠道改变成有氧状态有利自己生长

一个健康的大肠大部分是没有氧气的,居住在那里的有益的微生物在这种厌氧环境中茁壮成长。相反,肠道致病菌,如人类中的大肠埃希氏杆菌Escherichia coli或小鼠中的柠檬酸杆菌Citrobacter rodentium,需要氧气才能生存。

Bäumler教授发现了这些病原体如何改变肠道环境,有利于自己的成长。

Bäumler教授说:肠道病原菌用毒力因子损伤肠壁,导致腹泻。为了修复损伤,机体加速了形成肠壁的上皮细胞的分裂,使未成熟的细胞移向粘膜表面。这些新的细胞中含有较多的氧,提高了整个大肠中的氧含量,创造出了一个使肠道病原菌如E. coli等胜出肠道厌氧微生物的环境。

Bäumler教授的研究对开发靶向造成肠道功能损伤的毒力因子,或者支持肠道健康菌群的组成提供对入侵微生物抗性的新方案有着重要的意义。

该发现在细菌耐药性时代的重要意义

Bäumler教授说:“抗生素耐药性的细菌菌株的崛起已成为全球重要的公共健康威胁,由于越来越多的细菌菌株对设计用来杀死它们药物没有反应。在过去的50年里治疗传染病取得的进步里现在是危险的。”

今年,美国疾病控制与预防中心(CDC)鉴定出三种耐药性有机体---难辨梭状芽孢杆菌、耐碳青霉烯类肠杆菌和淋病奈瑟氏菌,迫切需要关注。而且在5月,英国政府委托发布的一份报告预测到2050年,抗菌药物耐药性感染每年可能夺去1千万人的性命,且会给全球经济造成高达100万亿美元的损失。

了解肠道病原体如何操纵机体的自然防御机制,来让肠胃道内外处于异常状态是加州大学戴维斯分校一个新兴的研究领域。来自该分校的科学家正在研究抗生素的耐药性以及肠道菌群失衡的对多个方面的影响——包括大脑的健康和行为、肥胖、炎症性肠病、肠易激综合症、消化道癌症、心血管疾病、脂肪肝、自闭症、关节炎、哮喘。

原始出处:

Lopez CA1, Miller BM1, Rivera-Chávez F1, Velazquez EM1, Byndloss MX1, Chávez-Arroyo A1, Lokken KL1, Tsolis RM1, Winter SE2, Bäumler AJ3.Virulence factors enhance Citrobacter rodentium expansion through aerobic respiration.Science. 2016 Sep 16.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1770499, encodeId=91d51e70499a3, content=<a href='/topic/show?id=05fe2665508' target=_blank style='color:#2F92EE;'>#体能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26655, encryptionId=05fe2665508, topicName=体能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80ae38174281, createdName=liubm568, createdTime=Wed May 24 12:38:00 CST 2017, time=2017-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=144389, encodeId=a1d81443892e, content=好文章,长见识, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Tue Oct 11 15:05:34 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1375339, encodeId=be9f13e53391c, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Thu Sep 22 00:38:00 CST 2016, time=2016-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1510627, encodeId=4b88151062eae, content=<a href='/topic/show?id=2efbe0807b1' target=_blank style='color:#2F92EE;'>#病原体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70807, encryptionId=2efbe0807b1, topicName=病原体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6c210226313, createdName=xue8605, createdTime=Thu Sep 22 00:38:00 CST 2016, time=2016-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=132436, encodeId=502313243649, content=马克, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ef51928094, createdName=parapluie, createdTime=Wed Sep 21 17:48:00 CST 2016, time=2016-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131540, encodeId=e0e1131540e6, content=学习啦,,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Tue Sep 20 18:19:00 CST 2016, time=2016-09-20, status=1, ipAttribution=)]
    2017-05-24 liubm568
  2. [GetPortalCommentsPageByObjectIdResponse(id=1770499, encodeId=91d51e70499a3, content=<a href='/topic/show?id=05fe2665508' target=_blank style='color:#2F92EE;'>#体能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26655, encryptionId=05fe2665508, topicName=体能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80ae38174281, createdName=liubm568, createdTime=Wed May 24 12:38:00 CST 2017, time=2017-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=144389, encodeId=a1d81443892e, content=好文章,长见识, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Tue Oct 11 15:05:34 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1375339, encodeId=be9f13e53391c, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Thu Sep 22 00:38:00 CST 2016, time=2016-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1510627, encodeId=4b88151062eae, content=<a href='/topic/show?id=2efbe0807b1' target=_blank style='color:#2F92EE;'>#病原体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70807, encryptionId=2efbe0807b1, topicName=病原体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6c210226313, createdName=xue8605, createdTime=Thu Sep 22 00:38:00 CST 2016, time=2016-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=132436, encodeId=502313243649, content=马克, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ef51928094, createdName=parapluie, createdTime=Wed Sep 21 17:48:00 CST 2016, time=2016-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131540, encodeId=e0e1131540e6, content=学习啦,,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Tue Sep 20 18:19:00 CST 2016, time=2016-09-20, status=1, ipAttribution=)]
    2016-10-11 1e10c84am36(暂无匿称)

    好文章,长见识

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1770499, encodeId=91d51e70499a3, content=<a href='/topic/show?id=05fe2665508' target=_blank style='color:#2F92EE;'>#体能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26655, encryptionId=05fe2665508, topicName=体能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80ae38174281, createdName=liubm568, createdTime=Wed May 24 12:38:00 CST 2017, time=2017-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=144389, encodeId=a1d81443892e, content=好文章,长见识, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Tue Oct 11 15:05:34 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1375339, encodeId=be9f13e53391c, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Thu Sep 22 00:38:00 CST 2016, time=2016-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1510627, encodeId=4b88151062eae, content=<a href='/topic/show?id=2efbe0807b1' target=_blank style='color:#2F92EE;'>#病原体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70807, encryptionId=2efbe0807b1, topicName=病原体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6c210226313, createdName=xue8605, createdTime=Thu Sep 22 00:38:00 CST 2016, time=2016-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=132436, encodeId=502313243649, content=马克, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ef51928094, createdName=parapluie, createdTime=Wed Sep 21 17:48:00 CST 2016, time=2016-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131540, encodeId=e0e1131540e6, content=学习啦,,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Tue Sep 20 18:19:00 CST 2016, time=2016-09-20, status=1, ipAttribution=)]
    2016-09-22 jichang
  4. [GetPortalCommentsPageByObjectIdResponse(id=1770499, encodeId=91d51e70499a3, content=<a href='/topic/show?id=05fe2665508' target=_blank style='color:#2F92EE;'>#体能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26655, encryptionId=05fe2665508, topicName=体能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80ae38174281, createdName=liubm568, createdTime=Wed May 24 12:38:00 CST 2017, time=2017-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=144389, encodeId=a1d81443892e, content=好文章,长见识, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Tue Oct 11 15:05:34 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1375339, encodeId=be9f13e53391c, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Thu Sep 22 00:38:00 CST 2016, time=2016-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1510627, encodeId=4b88151062eae, content=<a href='/topic/show?id=2efbe0807b1' target=_blank style='color:#2F92EE;'>#病原体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70807, encryptionId=2efbe0807b1, topicName=病原体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6c210226313, createdName=xue8605, createdTime=Thu Sep 22 00:38:00 CST 2016, time=2016-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=132436, encodeId=502313243649, content=马克, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ef51928094, createdName=parapluie, createdTime=Wed Sep 21 17:48:00 CST 2016, time=2016-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131540, encodeId=e0e1131540e6, content=学习啦,,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Tue Sep 20 18:19:00 CST 2016, time=2016-09-20, status=1, ipAttribution=)]
    2016-09-22 xue8605
  5. [GetPortalCommentsPageByObjectIdResponse(id=1770499, encodeId=91d51e70499a3, content=<a href='/topic/show?id=05fe2665508' target=_blank style='color:#2F92EE;'>#体能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26655, encryptionId=05fe2665508, topicName=体能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80ae38174281, createdName=liubm568, createdTime=Wed May 24 12:38:00 CST 2017, time=2017-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=144389, encodeId=a1d81443892e, content=好文章,长见识, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Tue Oct 11 15:05:34 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1375339, encodeId=be9f13e53391c, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Thu Sep 22 00:38:00 CST 2016, time=2016-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1510627, encodeId=4b88151062eae, content=<a href='/topic/show?id=2efbe0807b1' target=_blank style='color:#2F92EE;'>#病原体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70807, encryptionId=2efbe0807b1, topicName=病原体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6c210226313, createdName=xue8605, createdTime=Thu Sep 22 00:38:00 CST 2016, time=2016-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=132436, encodeId=502313243649, content=马克, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ef51928094, createdName=parapluie, createdTime=Wed Sep 21 17:48:00 CST 2016, time=2016-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131540, encodeId=e0e1131540e6, content=学习啦,,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Tue Sep 20 18:19:00 CST 2016, time=2016-09-20, status=1, ipAttribution=)]
    2016-09-21 parapluie

    马克

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1770499, encodeId=91d51e70499a3, content=<a href='/topic/show?id=05fe2665508' target=_blank style='color:#2F92EE;'>#体能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26655, encryptionId=05fe2665508, topicName=体能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80ae38174281, createdName=liubm568, createdTime=Wed May 24 12:38:00 CST 2017, time=2017-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=144389, encodeId=a1d81443892e, content=好文章,长见识, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Tue Oct 11 15:05:34 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1375339, encodeId=be9f13e53391c, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Thu Sep 22 00:38:00 CST 2016, time=2016-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1510627, encodeId=4b88151062eae, content=<a href='/topic/show?id=2efbe0807b1' target=_blank style='color:#2F92EE;'>#病原体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70807, encryptionId=2efbe0807b1, topicName=病原体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6c210226313, createdName=xue8605, createdTime=Thu Sep 22 00:38:00 CST 2016, time=2016-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=132436, encodeId=502313243649, content=马克, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ef51928094, createdName=parapluie, createdTime=Wed Sep 21 17:48:00 CST 2016, time=2016-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131540, encodeId=e0e1131540e6, content=学习啦,,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Tue Sep 20 18:19:00 CST 2016, time=2016-09-20, status=1, ipAttribution=)]
    2016-09-20 医路开来

    学习啦,,,

    0

相关资讯

科学家发现3株新型诺如病毒,可造成肠道流行性疾病

(图片摘自www.sciencealert.com)澳大利亚科学家最近发现了三株新型的诺如病毒毒株,他们认为这几株病毒是造成最近几个月来病毒性肠胃炎的罪魁祸首。这次疫情子啊最严重的时候,其病例数量甚至超过了高峰时期的流感病毒。诺如病毒是一类由单链RNA编码的病毒,它能够造成呕吐,腹泻,恶心,以及短暂的味觉失灵。诺如病毒能够通过气溶胶颗粒以及被感染的粪便传播,它们在这些污染源表面停留的时间长达一周。

厦大周大旺教授发现新型小分子药物,促进肝脏肠道皮肤修复再生

近期,厦门大学两个科研团队联合攻关,研制出一种能促进受损的肝脏、肠道及皮肤等器官修复与再生的重要小分子药物,并在小鼠实验中取得了优异的治疗效果。也许未来的某一天,人们只需通过服药,便可实现受损肝脏、肠道和皮肤的修复与再生。这被认为为再生医学领域带来了新的“曙光”。 8月18日,这项研究成果发表在新一期美国《科学》杂志子刊——《科学转化医学》上,并作为封面文章进行重点推介。研究者是我校生命科学

Science:新型CD4 T细胞亚群调节肠道炎症反应

外周调节性T细胞(pTreg)对于限制由外源物质引起的炎症反应具有重要的作用。在肠道中,pTreg主要存在于固有层(lamina propria)中,而上皮间存在的CD4 T细胞同样具有抑制炎症反应的作用。这部分CD4 T细胞依赖视黄酸(Retinoic Acid)以及转化生长因子(TGF-b)发挥功能。为了研究肠道的炎症稳态调节过程中,pTreg以及CD4细胞分别发挥了怎样的作用,来自洛克

Cell Host & Microbe:良好的肠道关系或帮助抵御病原体入侵

抵抗肠道感染需要依赖肠道壁和肠道微生物细胞之间的动态关系,数百种不同的细菌和微生物共存于人体中并对人体无损害。这项研究揭示了当肠道上皮细胞产生的早期警报信号失效并威胁到机体第一道防线时,微生物如何适应特殊的补偿机制。 活性氧(ROS)是来源于氧气的活性化学分子。当白细胞重新吸收病原菌后超氧化物和相关化合物90就会杀死它们。ROS也会从肠道壁上皮释放出来用以处理病原体。如果体内RO

盘点:肠道菌群告诉我们关于抗生素使用的教训及全新替代方法

许多研究表明抗生素是一把双刃剑:既能够杀死导致感染的有害细菌,又会损耗我们的肠道菌群,损伤免疫系统,使我们在面对超级细菌感染的时候变得更加脆弱。在本站之前的报道中就曾有研究对抗生素的使用问题进行探讨。   在国际学术期刊Cell Host &Microbe上发表的一项最新研究中,来自美国加州大学戴维斯分校的研究人员以小鼠为模型,发现了抗生素治疗后肠道中发生的一系列变化,这些变化致